Read + Share
Richard N, Vuitton L, Fumery M. Letter: tricky reactions to switch back from subcutaneous to intravenous
vedolizumab in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2023;57:741-742.
PMID: 36821749
|
 |
|
Richard N, Vuitton L, Fumery M. Letter: tricky reactions to switch back from subcutaneous to intravenous
vedolizumab in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2023;57:741-742.
PMID: 36821749
|
|
|
|